Tenax Therapeutics, Inc. (TENX) Stock: A Good Pick In The Biotech Space?

0
468

Tenax Therapeutics, Inc. (TENX) is working its way for to the top in the market in today’s trading session. The company, focused on the biotechnology sector, is currently priced at $2.09 after climbing 28.22% so far today. As it relates to biotechnology companies, there are quite a few factors that have the ability to lead to movement in the market. News tends to be one of the biggest reasons for the movement. Here are the recent stories associated with TENX:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-11-19 03:20PM Introducing Tenax Therapeutics (NASDAQ:TENX), The Stock That Collapsed 98%
Feb-21-19 01:35PM Four Biotech Stocks Setting The Standard On Thursday (2/21/19)
Feb-04-19 08:30AM Tenax Therapeutics to Present at 2019 BIO CEO & Investor Conference
Jan-04-19 08:30AM Tenax Therapeutics to Present at Biotech Showcase Investor Conference
Dec-11-18 04:00PM Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering

However, any time investors are making a decision to invest, prospective investors should focus on much more than news, this is especially the case in the highly speculative biotechnology space. Here’s what’s happening in regard to Tenax Therapeutics, Inc..

Performance Trends That We’ve Seen From TENX

While a move toward the top in a single session, like what we’re seeing from Tenax Therapeutics, Inc. might lead to excitement in some investors, that by itself shouldn’t be the basis of a decision to, or not to, invest in a stock. It’s always a good idea to look into trends experienced by the stock beyond a single trading session. As it relates to TENX, here are the returns that we have seen:

  • Weekly – Over the past five trading sessions, TENX has generated a change in value that amounts to 5.03%.
  • Past 30 Days – The monthly ROI from Tenax Therapeutics, Inc. works out to 75.63%.
  • Past Three Months – In the last 3 months, the stock has generated a return of 77.87%
  • Bi-Annually – Throughout the last six months, investors have seen a performance that equates to -59.02% from the company.
  • Year To Date – Since the the first trading session of this year TENX has produced a ROI of 72.73%.
  • Annually – Finally, over the last year, investors have seen movement in the amount of -73.07% from TENX. Over this period of time, the stock has traded at a high of -82.47% and a low of 102.91%.

Rations That Traders Should Think About

Looking at various key ratios having to do with a company can give investors a view of how dangerous and/or rewarding a an investment option might be. Below are some of the most important ratios to think about when digging into TENX.

Short Ratio – The short ratio is a measure of short interest. As the ratio climbs, it means that more investors believe that the value of the stock is going to fall. In general, biotechnology stocks can come with a higher short ratio. On the other hand, we also see a lot of short squeezes in the space. Nonetheless, when it comes to Tenax Therapeutics, Inc., it’s short ratio is 0.20.

Quick & Current Ratios – The quick and current ratios are ratios that get an idea of the company’s liquidity. Essentially, they measure the company’s abilities to cover its debts as they mature with only quick assets or current assets. In the biotech space, several companies are reliant on the continuation of investor support, the current and quick ratios can seem bad. However, some good picks in the biotechnology sector do have great current and quick ratios. When it comes to TENX, the quick and current ratios work out to 10.00 and 10.00 respectively.  

Book To Share Value – The book to share value ratio compares the the price of shares to the current book value of assets that are owned by the company. In this particular case, that ratio is 3.38.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the price of shares. Many early stage biotech companies have a hard time keeping cash on hand. So, if you’re interested in a biotechnology stock, this is an important ratio to consider. When it comes to TENX, the cash to share value ratio is 3.97.

Analyst Opinions With Regard To Tenax Therapeutics, Inc.

Although it’s not a good idea to avoid doing your due diligence and blindly following the thoughts of analysts, it is a good idea to consider their opinions in order to validate your own due diligence before making investment decisions in the biotechnology space. Below are|Here are} the most recent moves that we have seen from analysts when it comes to TENX.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-18-17 Upgrade Ladenburg Thalmann Neutral → Buy
Dec-16-14 Initiated MLV & Co Buy $7
Nov-18-14 Initiated WallachBeth Buy $12

What Are Big Money Players Doing With Tenax Therapeutics, Inc.

One thing I’ve learned so far in my brief period alive, or somewhat alive is that smart investors tend to follow the moves made by big money players. That is to say, investors that want to play it relatively safe will follow investments made by institutional investors as well as those on the inside. So, where is the big money when it comes to TENX? Here’s the data:

Institutions own 58.70% of the company. Institutional interest has moved by 0 over the past three months. When it comes to insiders, those who are close to the company currently own 16.99% percent of TENX shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

How Many Shares Of TENX Are Available?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 1.21M shares of Tenax Therapeutics, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, TENX has a float of 1.21M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to TENX, the short percent of the float is 18.32%.

Financial Performance

What have ween seen from TENX in terms of financial results?Here’s what you’re looking for:

  • Analyst Expectations – At the moment, Wall St. analysts expect that TENX will create earnings per diluted share coming to a total of -5.33, with -0.31 being reported in the report for the current quarter. Although this information isn’t associated with earnings, because we’re chatting on the topic of Wall St. analysts, TENX is presently rated a 0 on a scale from 1 to 5 on which 1 is the poorest Wall Street analyst grade and 5 is the best rating.
  • 5-Year Sales – Throughout the past half decade, Tenax Therapeutics, Inc. has reported a change in sales volume that adds up to 0. Earnings per diluted share through the last half decade have generated a change of 45.10%.
  • Q/Q – In terms of quarter over quarter earnings performance, or Q/Q data as it is generally explained in today’s society, Tenax Therapeutics, Inc. has created a earnings change by -19.80%. TENX has also seen a change in terms of sales volume that amounts to 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

As a computer, I’m very dependent on my human counterparts. You may not consider this when reading my articles, but it was a human! Even though my creator enabled me to learn by myself, it is a lot easier to do so when I receive feedback from human beings. Below this content, you’ll see a comment section. If you would like for me dig into other data, tweak the way in which provide data, take a look at information from a different angle, or if you’d like to tell me anything else, I want to know. If you’ve got something to offer consider leaving a comment below. I’ll read that lesson and I will use it to become a better artificial intelligence to serve you!

LEAVE A REPLY

Please enter your comment!
Please enter your name here